Acushnet (GOLF) 10-Q 7 Nov 24 2024 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2024	Nov. 01, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	001-37935
Entity Registrant Name	Acushnet Holdings Corp.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	45-2644353
Entity Address, Address Line One	333 Bridge Street
Entity Address, City or Town	Fairhaven,
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	02719
City Area Code	800
Local Phone Number	225-8500
Title of 12(b) Security	Common Stock - $0.001 par value per share
Trading Symbol	GOLF
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		60,802,949
Entity Central Index Key	0001672013
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets
Cash, cash equivalents and restricted cash ($13,659 and $12,532 attributable to the variable interest entity ("VIE"))	$ 99,062	$ 65,435
Accounts receivable, net	367,519	201,352
Inventories ($3,276 and $9,621 attributable to the VIE)	497,519	615,535
Prepaid and other assets	121,349	114,370
Total current assets	1,085,449	996,692
Property, plant and equipment, net ($8,363 and $9,044 attributable to the VIE)	311,582	295,343
Goodwill ($32,312 and $32,312 attributable to the VIE)	225,130	225,302
Intangible assets, net	526,856	537,407
Deferred income taxes	25,382	31,454
Other assets ($1,916 and $1,972 attributable to the VIE)	106,349	110,479
Total assets	2,280,748	2,196,677
Current liabilities
Short-term debt	21,165	28,997
Current portion of long-term debt	788	351
Accounts payable ($3,064 and $6,059 attributable to the VIE)	166,335	150,514
Accrued taxes	51,420	46,398
Accrued compensation and benefits ($720 and $1,233 attributable to the VIE)	102,812	111,136
Accrued expenses and other liabilities ($3,282 and $1,687 attributable to the VIE)	173,192	113,739
Total current liabilities	515,712	451,135
Long-term debt	708,043	671,819
Deferred income taxes	7,620	7,080
Accrued pension and other postretirement benefits	66,063	69,634
Other noncurrent liabilities	78,189	84,137
Total liabilities	1,375,627	1,283,805
Commitments and contingencies (Note 15)
Redeemable noncontrolling interests	6,519	9,785
Shareholders' equity
Common stock, $0.001 par value, 500,000,000 shares authorized; 61,655,989 and 63,429,243 shares issued	62	63
Additional paid-in capital	787,248	808,615
Accumulated other comprehensive loss, net of tax	(108,099)	(104,349)
Retained earnings	217,211	159,906
Treasury stock, at cost; (493,040 of accrued share repurchases) (Note 10)	(32,523)	0
Total equity attributable to Acushnet Holdings Corp.	863,899	864,235
Noncontrolling interests	34,703	38,852
Total shareholders' equity	898,602	903,087
Total liabilities, redeemable noncontrolling interests and shareholders' equity	$ 2,280,748	$ 2,196,677

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Cash, cash equivalents and restricted cash	$ 99,062	$ 65,435
Inventories	497,519	615,535
Property, plant and equipment, net	311,582	295,343
Goodwill	225,130	225,302
Other assets	106,349	110,479
Accounts payable	166,335	150,514
Accrued compensation and benefits	102,812	111,136
Accrued expenses and other liabilities	$ 173,192	$ 113,739
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	61,655,989	63,429,243
Treasury stock, at cost (in shares)	493,040	493,040
VIE
Cash, cash equivalents and restricted cash	$ 13,659	$ 12,532
Inventories	3,276	9,621
Property, plant and equipment, net	8,363	9,044
Goodwill	32,312	32,312
Other assets	1,916	1,972
Accounts payable	3,064	6,059
Accrued compensation and benefits	720	1,233
Accrued expenses and other liabilities	$ 3,282	$ 1,687

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Net sales	$ 620,501	$ 593,381	$ 2,011,922	$ 1,969,034
Cost of goods sold	283,126	284,859	924,854	926,317
Gross profit	337,375	308,522	1,087,068	1,042,717
Operating expenses:
Selling, general and administrative	232,882	210,166	715,558	674,720
Research and development	18,923	16,239	51,516	47,286
Intangible amortization	3,503	3,512	10,523	10,712
Income from operations	82,067	78,605	309,471	309,999
Interest expense, net	13,187	9,389	40,367	30,234
Other expense, net	407	918	1,289	2,010
Income before income taxes	68,473	68,298	267,815	277,755
Income tax expense	13,198	11,252	57,817	52,726
Net income	55,275	57,046	209,998	225,029
Less: Net loss attributable to noncontrolling interests	949	261	5,416	208
Net income attributable to Acushnet Holdings Corp.	$ 56,224	$ 57,307	$ 215,414	$ 225,237
Net income per common share attributable to Acushnet Holdings Corp.:
Basic (in dollars per share)	$ 0.89	$ 0.86	$ 3.38	$ 3.32
Diluted (in dollars per share)	$ 0.89	$ 0.85	$ 3.36	$ 3.30
Weighted average number of common shares:
Basic (in shares)	62,894,940	66,898,142	63,813,805	67,812,790
Diluted (in shares)	63,171,736	67,343,260	64,070,500	68,208,022

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 55,275	$ 57,046	$ 209,998	$ 225,029
Other comprehensive income (loss):
Foreign currency translation adjustments	20,619	(10,991)	1,559	(12,919)
Cash flow derivative instruments:
Unrealized holding (losses) gains arising during period	(3,893)	4,090	2,213	8,320
Reclassification adjustments included in net income	(3,296)	(923)	(9,216)	(7,404)
Tax benefit (expense)	2,158	(807)	2,269	(269)
Cash flow derivative instruments, net	(5,031)	2,360	(4,734)	647
Pension and other postretirement benefits:
Pension and other postretirement benefits adjustments	(541)	190	(794)	(914)
Tax benefit (expense)	114	(32)	175	216
Pension and other postretirement benefits adjustments, net	(427)	158	(619)	(698)
Total other comprehensive income (loss)	15,161	(8,473)	(3,794)	(12,970)
Comprehensive income	70,436	48,573	206,204	212,059
Less: Comprehensive loss attributable to noncontrolling interests	727	309	5,460	76
Comprehensive income attributable to Acushnet Holdings Corp.	$ 71,163	$ 48,882	$ 211,664	$ 212,135

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities
Net income	$ 209,998	$ 225,029
Adjustments to reconcile net income to cash flows provided by operating activities
Depreciation and amortization	41,716	38,181
Unrealized foreign exchange loss (gain)	159	(2,495)
Amortization of debt issuance costs	1,307	501
Share-based compensation	23,998	21,369
Loss (gain) on disposals of property, plant and equipment	760	(19)
Deferred income taxes	8,953	25,015
Changes in operating assets and liabilities
Accounts receivable	(165,730)	(125,667)
Inventories	116,687	136,828
Accounts payable	9,453	(30,030)
Accrued taxes	4,582	5,798
Other assets and liabilities	(5,655)	2,420
Cash flows provided by operating activities	246,228	296,930
Cash flows from investing activities
Additions to property, plant and equipment	(42,522)	(42,432)
Additions to intangible assets (Note 17)	0	(25,235)
Other, net	0	(887)
Cash flows used in investing activities	(42,522)	(68,554)
Cash flows from financing activities
Repayments of short-term borrowings, net (Note $5)	0	(3,121)
Proceeds from credit facilities (Note $5)	951,480	1,039,443
Repayments of credit facilities (Note $5)	(922,666)	(1,010,387)
Purchases of common stock	(142,343)	(204,656)
Dividends paid on common stock	(41,282)	(40,099)
Payment of employee restricted stock tax withholdings	(16,864)	(11,460)
Other, net	0	1,078
Cash flows used in financing activities	(171,675)	(229,202)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash	1,596	(1,312)
Net increase (decrease) in cash, cash equivalents and restricted cash	33,627	(2,138)
Cash, cash equivalents and restricted cash, beginning of year	65,435	58,904
Cash, cash equivalents and restricted cash, end of period	99,062	56,766
Supplemental non-cash information
Purchases of property, plant and equipment, accrued not paid	6,999	6,007
Additions to right-of-use assets obtained in exchange for operating lease obligations	7,651	50,813
Additions to right-of-use assets obtained in exchange for finance lease obligations	434	711
Dividend equivalents rights ("DERs") declared not paid	1,521	1,411
Share repurchase liability (Note 10)	$ 32,523	$ 79,765

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	Total	Total Shareholders' Equity Attributable to Acushnet Holdings Corp.	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss, Net of Tax	Retained Earnings	Treasury Stock	Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2022			76,322
Beginning balance at Dec. 31, 2022	$ 976,703	$ 939,056	$ 76	$ 960,685	$ (109,668)	$ 473,130	$ (385,167)	$ 37,647
Changes in stockholders' equity
Sale of equity to redeemable noncontrolling interest	264	264		444		(180)
Net income (loss)	225,870	225,237				225,237		633
Other comprehensive loss (income)	(13,102)	(13,102)			(13,102)
Share-based compensation	20,877	20,877		20,877
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)			484
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11)	(11,359)	(11,359)	$ 1	(11,360)
Purchases of common stock (Note 10)	(112,448)	(112,448)					(112,448)
Share repurchase liability (Note 10)	(79,765)	(79,765)					(79,765)
Dividends and dividend equivalents declared	(40,394)	(40,394)				(40,394)
Ending balance (in shares) at Sep. 30, 2023			76,806
Ending balance at Sep. 30, 2023	966,646	928,366	$ 77	970,646	(122,770)	657,793	(577,380)	38,280
Beginning balance (in shares) at Dec. 31, 2022			76,322
Beginning balance at Dec. 31, 2022	976,703	939,056	$ 76	960,685	(109,668)	473,130	(385,167)	37,647
Changes in stockholders' equity
Dividends and dividend equivalents declared	(53,335)
Ending balance (in shares) at Dec. 31, 2023			63,429
Ending balance at Dec. 31, 2023	903,087	864,235	$ 63	808,615	(104,349)	159,906	0	38,852
Beginning balance (in shares) at Jun. 30, 2023			76,782
Beginning balance at Jun. 30, 2023	1,055,217	1,017,219	$ 77	965,446	(114,345)	613,584	(447,543)	37,998
Changes in stockholders' equity
Net income (loss)	57,589	57,307				57,307		282
Other comprehensive loss (income)	(8,425)	(8,425)			(8,425)
Share-based compensation	5,141	5,141		5,141
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)			24
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11)	59	59		59
Purchases of common stock (Note 10)	(64,918)	(64,918)					(64,918)
Share repurchase liability (Note 10)	(64,919)	(64,919)					(64,919)
Dividends and dividend equivalents declared	(13,098)	(13,098)				(13,098)
Ending balance (in shares) at Sep. 30, 2023			76,806
Ending balance at Sep. 30, 2023	966,646	928,366	$ 77	970,646	(122,770)	657,793	(577,380)	38,280
Changes in stockholders' equity
Dividends and dividend equivalents declared	(12,941)
Ending balance (in shares) at Dec. 31, 2023			63,429
Ending balance at Dec. 31, 2023	903,087	864,235	$ 63	808,615	(104,349)	159,906	0	38,852
Changes in stockholders' equity
Net income (loss)	211,265	215,414				215,414		(4,149)
Other comprehensive loss (income)	(3,750)	(3,750)			(3,750)
Share-based compensation	23,522	23,522		23,522
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)			442
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11)	(16,600)	(16,600)		(16,600)
Purchases of common stock (Note 10) (in shares)			(2,215)
Purchases of common stock (Note 10)	(143,584)	(143,584)	$ (1)	(28,289)		(115,294)
Share repurchase liability (Note 10)	(32,523)	(32,523)					(32,523)
Dividends and dividend equivalents declared	(41,815)	(41,815)				(41,815)
Redemption value adjustment (Note 1)	(1,000)	(1,000)				(1,000)
Ending balance (in shares) at Sep. 30, 2024			61,656
Ending balance at Sep. 30, 2024	898,602	863,899	$ 62	787,248	(108,099)	217,211	(32,523)	34,703
Beginning balance (in shares) at Jun. 30, 2024			62,729
Beginning balance at Jun. 30, 2024	898,709	863,693	$ 63	792,559	(123,038)	231,608	(37,499)	35,016
Changes in stockholders' equity
Net income (loss)	55,911	56,224				56,224		(313)
Other comprehensive loss (income)	14,939	14,939			14,939
Share-based compensation	8,883	8,883		8,883
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)			7
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11)	(246)	(246)		(246)
Purchases of common stock (Note 10) (in shares)			(1,080)
Purchases of common stock (Note 10)	(70,783)	(70,783)	$ (1)	(13,948)		(56,834)
Share repurchase liability (Note 10)	4,976	4,976					4,976
Dividends and dividend equivalents declared	(13,787)	(13,787)				(13,787)
Ending balance (in shares) at Sep. 30, 2024			61,656
Ending balance at Sep. 30, 2024	$ 898,602	$ 863,899	$ 62	$ 787,248	$ (108,099)	$ 217,211	$ (32,523)	$ 34,703

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) and include the accounts of Acushnet Holdings Corp. (the “Company”), its wholly-owned subsidiaries and less than wholly-owned subsidiaries, including a variable interest entity (“VIE”) in which the Company is the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation. Certain information in footnote disclosures normally included in annual financial statements has been condensed or omitted for the interim periods presented in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) and U.S. GAAP. The year-end balance sheet data was derived from audited financial statements; however, the accompanying interim notes to the unaudited condensed consolidated financial statements do not include all disclosures required by U.S. GAAP. In the opinion of management, the financial statements contain all normal and recurring adjustments necessary to state fairly the financial position and results of operations of the Company. The results of operations for the three and nine months ended September 30, 2024 are not necessarily indicative of results to be expected for the full year ending December 31, 2024, nor were those of the comparable 2023 periods representative of those actually experienced for the full year ended December 31, 2023. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the fiscal year ended December 31, 2023 included in its Annual Report on Form 10-K filed with the SEC on February 29, 2024. Use of Estimates The preparation of the Company’s unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Variable Interest Entities VIEs are entities that, by design, either (i) lack sufficient equity to permit the entity to finance its activities independently, or (ii) have equity holders that do not have the power to direct the activities of the entity that most significantly impact its economic performance, the obligation to absorb the entity’s expected losses, or the right to receive the entity’s expected residual returns. The Company consolidates a VIE when it is the primary beneficiary, which is the party that has both (i) the power to direct the activities that most significantly impact the VIE’s economic performance and (ii) through its interests in the VIE, the obligation to absorb expected losses or the right to receive expected benefits from the VIE that could potentially be significant to the VIE. The Company consolidates the accounts of Acushnet Lionscore Limited (“Lionscore”), a VIE which is 40% owned by the Company. The sole purpose of the VIE is to manufacture the Company’s golf footwear and as such, the Company is deemed to be the primary beneficiary. The Company has presented separately on its unaudited condensed consolidated balance sheets, to the extent material, the assets of its consolidated VIE that can only be used to settle specific obligations of its consolidated VIE and the liabilities of its consolidated VIE for which creditors do not have recourse to its general credit. The general creditors of the VIE do not have recourse to the Company. Certain directors of the VIE have guaranteed the credit lines of the VIE, for which there were no outstanding borrowings as of September 30, 2024 and December 31, 2023. In addition, pursuant to the terms of the agreement governing the VIE, the Company is not required to provide financial support to the VIE. Noncontrolling Interests and Redeemable Noncontrolling Interests The ownership interests held by owners other than the Company in less than wholly-owned subsidiaries are classified as noncontrolling interests. The financial results and position of noncontrolling interests are included in the Company’s unaudited condensed consolidated financial statements. The value attributable to the noncontrolling interests is presented on the unaudited condensed consolidated balance sheets, separately from the equity attributable to the Company. Net income (loss) and comprehensive income (loss) attributable to noncontrolling interests are presented separately on the unaudited condensed consolidated statements of operations and unaudited condensed consolidated statements of comprehensive income, respectively. Redeemable noncontrolling interests are those noncontrolling interests which are or may become redeemable at a fixed or determinable price on a fixed or determinable date, at the option of the holder, or upon occurrence of an event. The Company initially records the redeemable noncontrolling interest at its acquisition date fair value. The carrying amount of the redeemable noncontrolling interest is subsequently adjusted to the greater amount of either the initial carrying amount, increased or decreased for the redeemable noncontrolling interest's share of comprehensive income (loss) or the redemption value, assuming the noncontrolling interest is redeemable at the balance sheet date. This adjustment is recognized through retained earnings and is not reflected in net income (loss) or comprehensive income (loss). During the nine months ended September 30, 2024, the Company recorded a $1.0 million redemption value adjustment to increase the carrying amount of redeemable noncontrolling interests. The value attributable to redeemable noncontrolling interests and any related loans to minority shareholders, which are recorded as a reduction to redeemable noncontrolling interests, are presented in the unaudited condensed consolidated balance sheets as temporary equity between liabilities and shareholders’ equity. The amount of the loan to minority shareholders was $4.4 million as of both September 30, 2024 and December 31, 2023. Cash, Cash Equivalents and Restricted Cash Cash held in Company checking accounts is included in cash. Cash equivalents consist of short-term highly liquid investments with original maturities of three months or less which are readily convertible into cash. The Company classifies as restricted certain cash that is not available for use in its operations. As of both September 30, 2024 and December 31, 2023, the amount of restricted cash included in cash, cash equivalents and restricted cash on the unaudited condensed consolidated balance sheets was $1.7 million. Foreign Currency Transactions Foreign currency transaction losses included in selling, general and administrative expenses were less than $0.1 million and $0.9 million for the three months ended September 30, 2024 and 2023, respectively. Foreign currency transaction losses included in selling, general and administrative expenses were $1.0 million and $3.4 million for the nine months ended September 30, 2024 and 2023, respectively. Recently Issued Accounting Standards In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-07, "Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures." The amendments in this update improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact this standard will have on its consolidated financial statements and related disclosures. In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740) - Improvements to Income Tax Disclosures."

Allowance for Doubtful Accounts

Allowance for Doubtful Accounts	9 Months Ended
	Sep. 30, 2024
Receivables [Abstract]
Allowance for Doubtful Accounts	Allowance for Doubtful Accounts The Company estimates expected credit losses using a number of factors, including customer credit ratings, age of receivables, historical credit loss information and current and forecasted economic conditions, which could affect the collectability of the reported amounts. All these factors have been considered in the estimate of expected credit losses for the periods presented. The activity related to the allowance for doubtful accounts was as follows: Three months ended September 30, Nine months ended September 30, (in thousands) 2024 2023 2024 2023 Balance at beginning of period $ 9,123 $ 9,008 $ 8,840 $ 8,258 Bad debt (recovery) expense (207) 17 444 814 Amount of receivables written off (247) (239) (492) (341) Foreign currency translation 246 (124) 123 (69) Balance at end of period $ 8,915 $ 8,662 $ 8,915 $ 8,662

Inventories

Inventories	9 Months Ended
	Sep. 30, 2024
Inventory Disclosure [Abstract]
Inventories	Inventories The components of inventories were as follows: September 30, December 31, (in thousands) 2024 2023 Raw materials and supplies $ 133,944 $ 157,455 Work-in-process 28,027 24,949 Finished goods 335,548 433,131 Inventories $ 497,519 $ 615,535

Product Warranty

Product Warranty	9 Months Ended
	Sep. 30, 2024
Product Warranties Disclosures [Abstract]
Product Warranty	Product Warranty The Company has defined warranties generally ranging from one The activity related to the Company’s warranty obligation for accrued warranty expense was as follows: Three months ended September 30, Nine months ended September 30, (in thousands) 2024 2023 2024 2023 Balance at beginning of period $ 5,511 $ 5,049 $ 4,997 $ 3,951 Provision 1,325 1,568 5,123 5,313 Claims paid/costs incurred (1,511) (1,685) (4,708) (4,337) Foreign currency translation 83 (61) (4) (56) Balance at end of period $ 5,408 $ 4,871 $ 5,408 $ 4,871

Debt and Financing Arrangements

Debt and Financing Arrangements	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Debt and Financing Arrangements	Debt and Financing Arrangements Credit Facility The Company's credit agreement, dated as of December 23, 2019 (as subsequently amended on July 3, 2020 and August 2, 2022 (the "Credit Agreement")), provides for a $950.0 million multi-currency revolving credit facility, due to mature on August 2, 2027. On May 2, 2024, the Company entered into a third amendment (the “Third Amendment”) to its Credit Agreement (as so amended, the “Amended Credit Agreement”). On June 28, 2024, the Canadian Dollar Offered Rate (“CDOR”) ceased to be published (the “CORRA Transition Date”). Pursuant to the Third Amendment, for loans denominated in Canadian dollars borrowed or continued after the CORRA Transition Date, the Adjusted CDOR (as defined in the Credit Agreement) is replaced by adjusted term CORRA (the Canadian Overnight Repo Rate Average administered by Bank of Canada) plus a credit spread adjustment of 0.29547% (for a one-month Interest Period) or 0.32138% (for a three-month Interest Period) (“Adjusted Term CORRA”). The applicable margin for Adjusted Term CORRA loans remains 1.00% to 1.75%, depending on the Net Average Total Leverage Ratio (as defined in the Amended Credit Agreement). The Amended Credit Agreement contains customary affirmative and restrictive covenants, including, among others, financial covenants based on the Company's leverage and interest coverage ratios. The Amended Credit Agreement also includes customary events of default, the occurrence of which, following any applicable cure period, would permit the lenders to, among other things, declare the principal, accrued interest and other obligations to be immediately due and payable. As of September 30, 2024, the Company was in compliance with all covenants under its Amended Credit Agreement. As of September 30, 2024 and December 31, 2023, there were $359.4 million and $325.2 million, respectively, in outstanding borrowings under the Company's multi-currency revolving credit facility with a weighted average interest rate of 6.16% and 6.57%, respectively. As of September 30, 2024, the Company had available borrowings under its multi-currency revolving credit facility of $586.7 million after giving effect to $3.9 million of outstanding letters of credit. Senior Unsecured Notes On October 3, 2023, Acushnet Company (the "Issuer"), a wholly owned subsidiary of the Company, completed the issuance and sale of $350.0 million in gross proceeds of the Issuer's 7.375% senior unsecured notes due 2028 (the “Notes”). The Notes were issued pursuant to an Indenture, dated October 3, 2023 (the “Indenture”), among the Issuer, U.S. Bank Trust Company, National Association, as trustee of the Notes, and the Company and certain subsidiaries of the Issuer as guarantors. The proceeds from the Notes offering were used to repay $345.6 million of the outstanding borrowings under the Company's multi-currency revolving credit facility, as well as to pay fees and expenses related to the Notes offering. In connection with the Notes offering, the Company incurred fees and expenses of approximately $6.4 million, of which approximately $6.3 million was capitalized as debt issuance costs within long-term debt on the unaudited condensed consolidated balance sheet and is being amortized to interest expense, net over the term of the Notes using the effective interest rate method. The fair value of the Notes, based on third-party quotes (Level 2), as of September 30, 2024 and December 31, 2023 was $366.6 million and $365.1 million, respectively. The Notes bear interest at a stated interest rate of 7.375% (an effective interest rate of 7.813%) per year, with interest payable semi-annually on April 15 and October 15 of each year, beginning on April 15, 2024. Accrued interest related to the Notes of $12.0 million and $6.5 million was included within accrued expenses and other liabilities on the unaudited condensed consolidated balance sheets as of September 30, 2024 and December 31, 2023, respectively. The Indenture contains covenants that, among other things, limit the ability of the Company and its restricted subsidiaries to incur additional debt or issue certain preferred stock; pay dividends or repurchase or redeem capital stock; prepay, redeem or repurchase certain debt; make loans and investments; sell assets; incur liens; enter into certain types of transactions with the Company’s affiliates; and consolidate or merge with or into other companies. As of September 30, 2024, the Company was in compliance with all covenants under the Indenture. Other Short-Term Borrowings The Company has certain unsecured local credit facilities available through its subsidiaries. Amounts outstanding under other short-term borrowings are presented in short-term debt in the unaudited condensed consolidated balance sheets with the proceeds and repayments presented on a gross basis in the unaudited condensed consolidated statements of cash flows. There were $21.2 million and $29.0 million in outstanding borrowings under the Company's local credit facilities as of September 30, 2024 and December 31, 2023, respectively. The weighted average interest rate applicable to the outstanding borrowings was 0.59% and 0.45% as of September 30, 2024 and December 31, 2023, respectively. As of September 30, 2024, the Company had available borrowings remaining under these local credit facilities of $41.5 million. Letters of Credit

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The Company principally uses derivative financial instruments to reduce the impact of foreign currency fluctuations and interest rate variability on the Company's results of operations. The principal derivative financial instruments the Company enters into are foreign exchange forward contracts and interest rate swaps. The Company does not enter into derivative financial instrument contracts for trading or speculative purposes. Foreign Exchange Derivative Instruments Foreign exchange forward contracts are foreign exchange derivative instruments primarily used to reduce foreign currency risk related to transactions denominated in a currency other than functional currency. These instruments are designated as cash flow hedges. The periods of the foreign exchange forward contracts correspond to the periods of the hedged forecasted transactions, which do not exceed 24 months subsequent to the latest balance sheet date. The primary foreign exchange forward contracts pertain to the U.S. dollar, the Japanese yen, the British pound sterling, the Canadian dollar, the Korean won and the euro. The gross U.S. dollar equivalent notional amount outstanding of all foreign exchange forward contracts designated under hedge accounting as of September 30, 2024 and December 31, 2023 was $234.3 million and $209.6 million, respectively. Interest Rate Derivative Instruments From time to time, the Company enters into interest rate swap contracts to reduce interest rate risk related to floating rate debt. Under the contracts, the Company pays fixed and receives variable rate interest, in effect converting a portion of its floating rate debt to fixed rate debt. Interest rate swap contracts are accounted for as cash flow hedges. The notional value of the Company's outstanding interest rate swap contracts was $100.0 million as of September 30, 2024 and December 31, 2023. Impact on Financial Statements The fair value of hedge instruments recognized on the unaudited condensed consolidated balance sheets was as follows: (in thousands) September 30, December 31, Balance Sheet Location Hedge Instrument Type 2024 2023 Prepaid and other assets Foreign exchange forward $ 1,912 $ 4,378 Interest rate swap 79 452 Accrued expenses and other liabilities Foreign exchange forward 5,246 1,931 Interest rate swap 40 63 Other noncurrent liabilities Foreign exchange forward 19 — Interest rate swap — 88 The hedge instrument (losses) gains recognized in accumulated other comprehensive loss, net of tax was as follows: Three months ended Nine months ended September 30, September 30, (in thousands) 2024 2023 2024 2023 Type of hedge Foreign exchange forward $ (3,635) $ 3,658 $ 1,702 $ 6,719 Interest rate swap (258) 432 511 1,601 Total $ (3,893) $ 4,090 $ 2,213 $ 8,320 Gains and losses on derivative instruments designated as cash flow hedges are reclassified from accumulated other comprehensive loss, net of tax at the time the forecasted hedged transaction impacts the statements of operations or at the time the hedge is determined to be ineffective. Based on the current valuation, during the next 12 months the Company expects to reclassify a net gain of $0.3 million related to foreign exchange derivative instruments from accumulated other comprehensive loss, net of tax, into cost of goods sold and a net gain of less than $0.1 million related to interest rate derivative instruments from accumulated other comprehensive loss, net of tax, into interest expense, net. For further information related to amounts recognized in accumulated other comprehensive loss, net of tax, see Note 12. The hedge instrument gains (losses) recognized on the unaudited condensed consolidated statements of operations were as follows: Three months ended Nine months ended September 30, September 30, (in thousands) 2024 2023 2024 2023 Location of gains (losses) in statements of operations Foreign exchange forward: Cost of goods sold $ 3,040 $ 682 $ 8,443 $ 6,975 Selling, general and administrative (1) (1,634) 1,106 (253) 1,463 Total $ 1,406 $ 1,788 $ 8,190 $ 8,438 Interest Rate Swap: Interest expense, net $ 256 $ 241 $ 773 $ 429 Total $ 256 $ 241 $ 773 $ 429 _______________________________________________________________________________ (1) Relates to net (losses) gains on foreign exchange forward contracts derived from previously designated cash flow hedges. Credit Risk The Company enters into derivative contracts with major financial institutions with investment grade credit ratings and is exposed to credit losses in the event of non-performance by these financial institutions. This credit risk is generally limited to the unrealized gains in the derivative contracts. However, the Company monitors the credit quality of these financial institutions, as well as its own credit quality, and considers the risk of counterparty default to be minimal.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Certain assets and liabilities are carried at fair value under U.S. GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Assets and liabilities measured at fair value on a recurring basis as of September 30, 2024 were as follows: Fair Value Measurements as of September 30, 2024 using: (in thousands) Level 1 Level 2 Level 3 Balance Sheet Location Assets Rabbi trust $ 3,142 $ — $ — Prepaid and other assets Foreign exchange derivative instruments — 1,912 — Prepaid and other assets Interest rate derivative instruments — 79 — Prepaid and other assets Deferred compensation program assets 622 — — Other assets Total assets $ 3,764 $ 1,991 $ — Liabilities Foreign exchange derivative instruments $ — $ 5,246 $ — Accrued expenses and other liabilities Interest rate derivative instruments — 40 — Accrued expenses and other liabilities Deferred compensation program liabilities 622 — — Other noncurrent liabilities Foreign exchange derivative instruments — 19 — Other noncurrent liabilities Total liabilities $ 622 $ 5,305 $ — Assets and liabilities measured at fair value on a recurring basis as of December 31, 2023 were as follows: Fair Value Measurements as of December 31, 2023 using: (in thousands) Level 1 Level 2 Level 3 Balance Sheet Location Assets Rabbi trust $ 4,334 $ — $ — Prepaid and other assets Foreign exchange derivative instruments — 4,378 — Prepaid and other assets Interest rate derivative instruments — 452 — Prepaid and other assets Deferred compensation program assets 725 — — Other assets Total assets $ 5,059 $ 4,830 $ — Liabilities Foreign exchange derivative instruments $ — $ 1,931 $ — Accrued expenses and other liabilities Interest rate derivative instruments — 63 — Accrued expenses and other liabilities Deferred compensation program liabilities 725 — — Other noncurrent liabilities Interest rate derivative instruments — 88 — Other noncurrent liabilities Total liabilities $ 725 $ 2,082 $ — Rabbi trust assets are used to fund certain retirement obligations of the Company. The assets underlying the Rabbi trust are equity and fixed income exchange-traded funds. Deferred compensation program assets and liabilities represent a program where select employees could defer compensation until termination of employment. Effective July 29, 2011, this program was amended to cease all employee compensation deferrals and provided for the distribution of all previously deferred employee compensation. The program remains in effect with respect to the value attributable to the employer match contributed prior to July 29, 2011. Foreign exchange derivative instruments are foreign exchange forward contracts primarily used to limit currency risk that would otherwise result from changes in foreign exchange rates (Note 6). The Company uses the mid-price of foreign exchange forward rates as of the close of business on the valuation date to value each foreign exchange forward contract at each reporting period. Interest rate derivative instruments are interest rate swap contracts used to reduce interest rate risk related to the Company's floating rate debt (Note 6). The valuation for the interest rate swap is calculated as the net of the discounted future cash flows of the pay and receive legs of the swap. Mid-market interest rates on the valuation date are used to create the forward curve for floating legs and discount curve.

Pension and Other Postretiremen

Pension and Other Postretirement Benefits	9 Months Ended
	Sep. 30, 2024
Retirement Benefits [Abstract]
Pension and Other Postretirement Benefits	Pension and Other Postretirement Benefits Components of net periodic benefit cost (credit) were as follows: Pension Benefits Postretirement Benefits Three months ended September 30, (in thousands) 2024 2023 2024 2023 Components of net periodic benefit cost (credit) Service cost $ 1,327 $ 1,411 $ 84 $ 107 Interest cost 2,645 2,832 129 166 Expected return on plan assets (1,838) (1,966) — — Settlements 142 — — — Amortization of net loss (gain) 60 25 (252) (223) Amortization of prior service cost (credit) 24 45 (35) (35) Net periodic benefit cost (credit) $ 2,360 $ 2,347 $ (74) $ 15 Pension Benefits Postretirement Benefits Nine months ended September 30, (in thousands) 2024 2023 2024 2023 Components of net periodic benefit cost (credit) Service cost $ 3,958 $ 4,261 $ 250 $ 322 Interest cost 8,033 8,491 389 497 Expected return on plan assets (5,510) (5,894) — — Settlements 142 (27) — — Amortization of net loss (gain) 177 70 (760) (670) Amortization of prior service cost (credit) 70 137 (103) (103) Net periodic benefit cost (credit) $ 6,870 $ 7,038 $ (224) $ 46 The non-service cost components of net periodic benefit cost (credit) are included in other expense, net in the unaudited condensed consolidated statements of operations.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Income tax expense increased $1.9 million to $13.2 million for the three months ended September 30, 2024 compared to $11.3 million for the three months ended September 30, 2023. The Company’s effective tax rate ("ETR") was 19.3% for the three months ended September 30, 2024 compared to 16.5% for the three months ended September 30, 2023. Income tax expense increased $5.1 million to $57.8 million for the nine months ended September 30, 2024 compared to $52.7 million for the nine months ended September 30, 2023. The Company’s ETR was 21.6% for the nine months ended September 30, 2024 compared to 19.0% for the nine months ended September 30, 2023. The ETR for the three and nine months ended September 30, 2024 differed from the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and federal and state tax credits, as well as the U.S. taxation of foreign income and the Company's geographic mix of income. The ETR for the three and nine months ended September 30, 2023 differed from the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and federal and state tax credits, partially offset by the U.S. taxation of foreign income and the Company's geographic mix of income.

Common Stock

Common Stock	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Common Stock	Common Stock Dividends The Company declared dividends per common share, including DERs (Note 11), during the periods presented as follows: Dividends per Common Share Amount (in thousands) 2024: Third Quarter $ 0.215 $ 13,787 Second Quarter 0.215 13,873 First Quarter 0.215 14,155 Total dividends declared in 2024 $ 0.645 $ 41,815 2023: Fourth Quarter $ 0.195 $ 12,941 Third Quarter 0.195 13,098 Second Quarter 0.195 13,667 First Quarter 0.195 13,629 Total dividends declared in 2023 $ 0.780 $ 53,335 During the fourth quarter of 2024, the Company's Board of Directors declared a dividend of $0.215 per share of common stock to shareholders of record as of December 6, 2024 and payable on December 20, 2024. Share Repurchase Program As of September 30, 2024, the Board of Directors had authorized the Company to repurchase up to $1.0 billion of its issued and outstanding common stock. Share repurchases may be effected from time to time in open market or privately negotiated transactions, including transactions with affiliates, with the timing of purchases and the amount of stock purchased generally determined at the discretion of the Company consistent with the Company's general working capital needs and within the constraints of the Amended Credit Agreement and the Indenture (Note 5). This program may be extended or otherwise modified by the Board of Directors at any time and will remain in effect until completed or until terminated by the Board of Directors. On June 16, 2022, the Company entered into an agreement with Magnus Holdings Co., Ltd. ("Magnus") to purchase from Magnus an equal amount of its common stock as it purchases on the open market over the period of time from July 1, 2022 through January 13, 2023, up to an aggregate of $75.0 million, at the same weighted average per share price (the "2022 Agreement"). On August 30, 2022, the Company amended and restated the 2022 Agreement to increase the aggregate dollar amount of shares of its common stock that it would purchase from Magnus from $75.0 million to $100.0 million, (the "Amended and Restated 2022 Agreement"). In relation to this agreement, the Company recorded a share repurchase liability of $92.6 million for 2,000,839 shares of common stock, which was included in accrued expenses and other liabilities and treasury stock on the consolidated balance sheet as of December 31, 2022. Between January 1, 2023 and January 13, 2023, the Company purchased an additional 167,689 shares of its common stock on the open market for an aggregate of $7.4 million, bringing the cumulative total open market purchases since the inception of the 2022 Agreement to $100.0 million. As a result, on January 23, 2023, the Company purchased 2,168,528 shares of its common stock from Magnus for an aggregate of $100.0 million, in satisfaction of its obligation under the Amended and Restated 2022 Agreement. On June 9, 2023, the Company entered into an agreement with Magnus to purchase from Magnus an equal amount of its common stock as it purchases on the open market over the period of time from June 12, 2023 through October 27, 2023, up to an aggregate of $100.0 million, at the same weighted average per share price (the "2023 Agreement"). On November 3, 2023, the Company purchased 1,824,994 shares of its common stock from Magnus for an aggregate of $100.0 million in satisfaction of its obligation under the 2023 Agreement. On March 14, 2024, the Company entered into an agreement with Magnus to purchase from Magnus an equal amount of its common stock as it purchases on the open market over the period of time from April 1, 2024 through June 28, 2024, up to an aggregate of $37.5 million, at the same weighted average per share price (the "March 2024 Agreement"). On July 10, 2024, the Company purchased 587,520 shares of its common stock from Magnus for an aggregate of $37.5 million in satisfaction of its obligation under the March 2024 Agreement. On June 14, 2024, the Company entered into an agreement with Magnus to purchase from Magnus an equal amount of its common stock as it purchases on the open market over the period of time from July 1, 2024 through December 31, 2024, up to an aggregate of $62.5 million, at the same weighted average per share price (the "June 2024 Agreement"). In relation to this agreement, the Company recorded a share repurchase liability of $32.5 million for 493,040 shares of common stock, which was included in accrued expenses and other liabilities and treasury stock on the unaudited condensed consolidated balance sheet as of September 30, 2024. The Company's share repurchase activity for the periods presented was as follows: Three months ended September 30, Nine months ended September 30, (in thousands, except share and per share amounts) 2024 2023 2024 2023 Shares repurchased in the open market: Shares repurchased 493,040 1,153,400 1,627,793 1,982,289 Average price $ 65.96 $ 56.28 $ 64.70 $ 52.98 Aggregate value $ 32,522 $ 64,918 $ 105,323 $ 105,030 Shares repurchased from Magnus: Shares repurchased 587,520 — 587,520 2,168,528 Average price (1) $ 63.83 $ — $ 63.83 $ 46.11 Aggregate value $ 37,499 $ — $ 37,499 $ 100,001 Total shares repurchased: Shares repurchased 1,080,560 1,153,400 2,215,313 4,150,817 Average price $ 64.80 $ 56.28 $ 64.47 $ 49.40 Aggregate value (2) $ 70,021 $ 64,918 $ 142,822 $ 205,031 ___________________________________ (1) In accordance with the share repurchase agreements, shares purchased from Magnus are accrued for at the same weighted average price as those purchased on the open market, as if the purchase from Magnus had occurred on the same day. As such, the average price of Magnus repurchases during any given period will differ from open market repurchases due to the settlement of the previously recorded share repurchase liability, as well as open market purchases made after the completion of the Magnus share repurchase agreements. (2) Includes $0.5 million and $2.0 million related to shares repurchased not settled as of the nine months ended September 30, 2024 and 2023, respectively. As of September 30, 2024, the Company had $232.2 million remaining under the current share repurchase authorization, including $62.5 million related to the June 2024 Agreement. Common Stock Retirement The Company records retirements of repurchased common stock, upon either formal or constructive retirement, at cost and allocates the excess of the repurchase price over the par value of shares acquired to both retained earnings and additional paid-in capital. The portion allocated to additional paid-in capital is calculated on a pro rata basis of the shares to be retired and the total shares issued and outstanding as of the date of retirement. When shares of common stock are retired, they are deducted from the number of shares issued. As of September 30, 2024, the Company presented as retired 2,215,313 shares of its repurchased common stock with an aggregate value of $143.6 million, including $0.8 million of excise tax on the shares repurchased, which the company intends to formally retire in 2024.

Equity Incentive Plans

Equity Incentive Plans	9 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Equity Incentive Plans	Equity Incentive Plans Under the Acushnet Holdings Corp. 2015 Omnibus Incentive Plan (the “2015 Plan”), the Company may grant stock options, stock appreciation rights, restricted shares of common stock, restricted stock units ("RSUs"), performance stock units ("PSUs") and other share-based and cash-based awards to members of the Board of Directors, officers, employees, consultants and advisors of the Company. As of September 30, 2024, the only awards granted under the 2015 Plan were RSUs and PSUs. Restricted Stock and Performance Stock Units RSUs granted to members of the Board of Directors vest immediately into shares of common stock. RSUs granted to Company officers generally vest over three years, with one-third of each grant vesting annually, subject to the recipient's continued employment with the Company. RSUs granted to other employees, consultants and advisors of the Company vest in accordance with the terms of the grants, generally either over three years or, beginning in 2022, with one-third of each grant vesting annually, subject to the recipient’s continued service to the Company. PSUs granted to Company officers and other employees vest based upon the Company's performance against specified targets, generally over a three-year performance period, subject to the recipient's continued service to the Company. At the end of the performance period, the number of shares of common stock that could be issued is determined based upon the Company's performance against these targets. The number of shares that could be issued can range from 0% to 200% of the recipient's target award. Recipients of the awards granted under the 2015 Plan may elect to defer receipt of all or any portion of any shares of common stock issuable upon vesting to a future date elected by the recipient. All RSUs and PSUs granted under the 2015 Plan have DERs, which entitle holders of RSUs and PSUs to the same dividend value per share as holders of common stock and can be paid in either cash or common stock. DERs are subject to the same vesting and other terms and conditions as the corresponding unvested RSUs and PSUs. DERs are paid when the underlying shares of common stock are delivered. A summary of the Company’s RSUs and PSUs as of September 30, 2024 and changes during the nine months then ended is presented below: Weighted- Weighted- Number Average Number Average of RSUs Fair Value RSUs of PSUs (3) Fair Value PSUs Outstanding as of December 31, 2023 868,063 $ 46.45 480,254 $ 46.07 Granted 309,293 66.70 156,087 66.77 Vested (1)(2) (492,950) 46.51 (133,099) 45.36 Forfeited (20,635) 36.42 (2,275) 56.40 Outstanding as of September 30, 2024 663,771 $ 56.16 500,967 $ 52.66 _______________________________________________________________________________ (1) Includes 54,117 shares of common stock related to RSU's that were not delivered as of September 30, 2024. (2) Based upon the Company’s level of achievement of the applicable performance metrics, the recipients of the 133,099 PSUs that vested during the nine months ended September 30, 2024, were entitled to receive 266,198 shares of common stock. As of September 30, 2024, there were 86,762 shares of common stock that had not been delivered in connection with the vesting of these PSUs. (3) Number of PSUs reflects 100% of the target level grant and may not be indicative of the performance level expected to be achieved. Compensation expense recorded related to the Company's RSUs and PSUs in the unaudited condensed consolidated statements of operations was as follows: Three months ended Nine months ended September 30, September 30, (in thousands) 2024 2023 2024 2023 RSUs $ 4,505 $ 4,012 $ 14,633 $ 12,966 PSUs 4,378 1,129 8,889 7,911 The remaining unrecognized compensation expense related to unvested RSUs and unvested PSUs was $25.3 million and $16.5 million, respectively, as of September 30, 2024, and is expected to be recognized over the related weighted average period of 1.4 years and 1.9 years, respectively. A summary of shares of common stock issued related to the 2015 Plan, including the impact of any DERs issued in common stock, is presented below: Nine months ended Nine months ended September 30, 2024 September 30, 2023 RSUs PSUs RSUs PSUs Shares of common stock issued 477,642 219,831 472,766 231,580 Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations (159,600) (95,814) (128,291) (91,842) Net shares of common stock issued 318,042 124,017 344,475 139,738 Cumulative undelivered shares of common stock 480,608 471,078 457,703 420,447 Compensation Expense The allocation of share-based compensation expense in the unaudited condensed consolidated statements of operations was as follows: Three months ended Nine months ended September 30, September 30, (in thousands) 2024 2023 2024 2023 Cost of goods sold $ 439 $ 340 $ 1,242 $ 1,095 Selling, general and administrative 8,207 4,629 21,524 18,875 Research and development 385 336 1,232 1,399 Total compensation expense before income tax 9,031 5,305 23,998 21,369 Income tax benefit 2,024 945 5,433 4,304 Total compensation expense, net of income tax $ 7,007 $ 4,360 $ 18,565 $ 17,065

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss, Net of Tax	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Accumulated Other Comprehensive Loss, Net of Tax	Accumulated Other Comprehensive Loss, Net of Tax Accumulated other comprehensive loss, net of tax consists of foreign currency translation adjustments, unrealized gains and losses from derivative instruments designated as cash flow hedges (Note 6) and pension and other postretirement adjustments (Note 8). The components of and adjustments to accumulated other comprehensive loss, net of tax, were as follows: Foreign Interest Accumulated Foreign Exchange Rate Swap Pension and Other Currency Derivative Derivative Other Comprehensive (in thousands) Translation Instruments Instruments Postretirement Loss, Net of Tax Balance as of December 31, 2023 $ (95,425) $ 3,929 $ 227 $ (13,080) $ (104,349) Other comprehensive income (loss) before reclassifications 1,603 1,702 511 (320) 3,496 Amounts reclassified from accumulated other comprehensive loss, net of tax — (8,443) (773) (474) (9,690) Tax benefit — 2,205 64 175 2,444 Balance as of September 30, 2024 $ (93,822) $ (607) $ 29 $ (13,699) $ (108,099)

Net Income per Common Share

Net Income per Common Share	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Net Income per Common Share	Net Income per Common Share The following is a computation of basic and diluted net income per common share attributable to Acushnet Holdings Corp.: Three months ended Nine months ended September 30, September 30, (in thousands, except share and per share amounts) 2024 2023 2024 2023 Net income attributable to Acushnet Holdings Corp. $ 56,224 $ 57,307 $ 215,414 $ 225,237 Weighted average number of common shares: Basic 62,894,940 66,898,142 63,813,805 67,812,790 RSUs 200,837 328,411 214,899 290,274 PSUs 75,959 116,707 41,796 104,958 Diluted 63,171,736 67,343,260 64,070,500 68,208,022 Net income per common share attributable to Acushnet Holdings Corp.: Basic $ 0.89 $ 0.86 $ 3.38 $ 3.32 Diluted $ 0.89 $ 0.85 $ 3.36 $ 3.30 Net income per common share attributable to Acushnet Holdings Corp. was calculated using the treasury stock method. The Company’s potential dilutive securities for the three and nine months ended September 30, 2024 and 2023 include RSUs and PSUs. PSUs vest based upon achievement of performance targets and are excluded from the diluted shares outstanding unless the performance targets have been met as of the end of the applicable reporting period regardless of whether such performance targets are probable of achievement. During 2024 and 2023, the minimum performance target was achieved relating to certain PSUs and as a result, these PSUs have been included in diluted shares outstanding for the three and nine months ended September 30, 2024 and September 30, 2023. The following securities have been excluded from the calculation of diluted weighted-average common shares outstanding as their impact was determined to be anti-dilutive: Three months ended Nine months ended September 30, September 30, 2024 2023 2024 2023 RSUs 201,512 — 212,224 86,499

Segment Information

Segment Information	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Segment Information	Segment Information The Company’s operating segments are based on how the Chief Operating Decision Maker (“CODM”) makes decisions about assessing performance and allocating resources. The Company currently has four reportable segments, organized on the basis of product categories: (i) Titleist golf balls, (ii) Titleist golf clubs, (iii) Titleist golf gear and (iv) FootJoy golf wear. The CODM primarily evaluates performance using segment operating income. Segment operating income includes directly attributable expenses and certain shared costs of corporate administration that are allocated to the reportable segments, but excludes certain other costs, such as interest expense, net; restructuring costs; the non-service cost component of net periodic benefit cost; transaction fees; as well as certain other non-operating gains and losses that the Company does not allocate to the reportable segments. The CODM does not evaluate a measure of assets when assessing performance. Results shown for the three and nine months ended September 30, 2024 and 2023 are not necessarily those which would be achieved if each segment was an unaffiliated business enterprise. There are no intersegment transactions. Information by reportable segment and a reconciliation to reported amounts are as follows: Three months ended September 30, Nine months ended September 30, (in thousands) 2024 2023 2024 2023 Net sales Titleist golf balls $ 190,560 $ 192,557 $ 646,017 $ 622,125 Titleist golf clubs 213,907 181,045 595,311 549,846 Titleist golf gear 51,574 47,657 188,661 184,571 FootJoy golf wear 133,137 136,669 482,753 500,174 Other 31,323 35,453 99,180 112,318 Total net sales $ 620,501 $ 593,381 $ 2,011,922 $ 1,969,034 Segment operating income Titleist golf balls $ 31,150 $ 43,770 $ 134,334 $ 131,591 Titleist golf clubs 49,930 36,509 124,670 118,455 Titleist golf gear 4,246 788 28,270 26,657 FootJoy golf wear 502 (1,469) 34,814 32,927 Other 804 1,693 7,348 12,606 Total segment operating income 86,632 81,291 329,436 322,236 Reconciling items: Interest expense, net (13,187) (9,389) (40,367) (30,234) Non-service cost component of net periodic benefit cost (875) (844) (2,438) (2,501) Other (1) (4,097) (2,760) (18,816) (11,746) Total income before income tax $ 68,473 $ 68,298 $ 267,815 $ 277,755 _______________________________________________________________________________ (1) For the nine months ended September 30, 2024, includes $7.0 million related to restructuring costs associated with the closure of certain production lines at the VIE's Fujian Fuh Deh Leh (“FDL”) factory (Note 16). Information as to the Company’s operations in different geographical areas is presented below. Net sales are categorized based on the location in which the sale originates. Three months ended September 30, Nine months ended September 30, (in thousands) 2024 2023 2024 2023 United States $ 374,219 $ 352,463 $ 1,200,989 $ 1,123,766 EMEA (1) 75,496 75,643 263,850 266,502 Japan 41,738 39,035 108,731 118,183 Korea 67,091 65,652 226,167 241,267 Rest of World 61,957 60,588 212,185 219,316 Total net sales $ 620,501 $ 593,381 $ 2,011,922 $ 1,969,034 _______________________________________________________________________________ (1) Europe, the Middle East and Africa ("EMEA") In the fourth quarter of 2024, the CODM changed how they will evaluate the Company’s performance and allocate resources as a result of ongoing strategic convergence between the golf ball and golf club businesses. Concurrently, the Company updated its internal reporting, including the information provided to the CODM and as such, expects to update its reportable segments in its annual report on Form 10-K for the period ending December 31, 2024. Following these changes, the Company will have three reportable segments: (i) Titleist golf equipment, which will include the previous Titleist golf balls and Titleist golf clubs reportable segments, (ii) Golf gear and (iii) FootJoy golf wear. The Company’s activities that do not meet the criteria to be considered a reportable segment will continue to be reported within Other.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Purchase Obligations During the normal course of its business, the Company enters into agreements to purchase goods and services, including purchase commitments for advertising (including media placement and production costs), finished goods inventory, capital expenditures and endorsement arrangements with professional golfers. The Company's purchase obligations as of September 30, 2024 were as follows: Payments Due by Period Remainder of (in thousands) 2024 2025 2026 2027 2028 Thereafter Purchase obligations (1) $ 237,533 $ 62,158 $ 5,392 $ 2,483 $ 2,417 $ 7,240 _______________________________________________________________________________ (1) The reported amounts exclude those liabilities included in accounts payable or accrued liabilities on the unaudited condensed consolidated balance sheet as of September 30, 2024. Litigation

Restructuring Costs

Restructuring Costs	9 Months Ended
	Sep. 30, 2024
Restructuring and Related Activities [Abstract]
Restructuring Costs	Restructuring Costs During the first quarter of 2024, Lionscore approved a plan to permanently close certain production lines at the VIE's FDL factory and involuntarily separate certain direct and indirect manufacturing employees during 2024, as footwear and production volume is shifted to a third-party supplier (the "Plan"). The remaining direct and indirect manufacturing employees at FDL continue to service the remaining production lines. In relation to the Plan, during the nine months ended September 30, 2024, the Company recorded involuntary employee termination costs of $7.0 million included in selling, general and administrative expenses on the unaudited condensed consolidated statement of operations. Accrued restructuring costs associated with the Plan are included within accrued expenses and other liabilities on the unaudited condensed consolidated balance sheet as they are expected to be paid out within a year. There are no further material costs expected to be incurred in relation to the Plan. See Note 1 for further information. The activity related to the Plan was as follows: (in thousands) Three months ended September 30, 2024 Nine months ended September 30, 2024 Balance at beginning of period $ 2,013 $ — Provision — 6,967 Payments (386) (5,340) Balance at end of period $ 1,627 $ 1,627

Other Business Developments

Other Business Developments	9 Months Ended
	Sep. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Other Business Developments	Other Business Developments In January 2023, the Company acquired certain trademarks from West Coast Trends, Inc., an industry leader specializing in Club Glove premium performance golf travel products, for $25.2 million including cash consideration of $22.2 million and contingent consideration of $3.0 million, which was subsequently paid in 2023. The trademarks acquired were included in the Company's Titleist golf gear reporting segment and will be amortized over a weighted average life of 10 years.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) and include the accounts of Acushnet Holdings Corp. (the “Company”), its wholly-owned subsidiaries and less than wholly-owned subsidiaries, including a variable interest entity (“VIE”) in which the Company is the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of the Company’s unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Variable Interest Entities	Variable Interest Entities VIEs are entities that, by design, either (i) lack sufficient equity to permit the entity to finance its activities independently, or (ii) have equity holders that do not have the power to direct the activities of the entity that most significantly impact its economic performance, the obligation to absorb the entity’s expected losses, or the right to receive the entity’s expected residual returns. The Company consolidates a VIE when it is the primary beneficiary, which is the party that has both (i) the power to direct the activities that most significantly impact the VIE’s economic performance and (ii) through its interests in the VIE, the obligation to absorb expected losses or the right to receive expected benefits from the VIE that could potentially be significant to the VIE. The Company consolidates the accounts of Acushnet Lionscore Limited (“Lionscore”), a VIE which is 40% owned by the Company. The sole purpose of the VIE is to manufacture the Company’s golf footwear and as such, the Company is deemed to be the primary beneficiary. The Company has presented separately on its unaudited condensed consolidated balance sheets, to the extent material, the assets of its consolidated VIE that can only be used to settle specific obligations of its consolidated VIE and the liabilities of its consolidated VIE for which creditors do not have recourse to its general credit. The general creditors of the VIE do not have recourse to the Company. Certain directors of the VIE have guaranteed the credit lines of the VIE, for which there were no outstanding borrowings as of September 30, 2024 and December 31, 2023. In addition, pursuant to the terms of the agreement governing the VIE, the Company is not required to provide financial support to the VIE.
Noncontrolling Interests and Redeemable Noncontrolling Interests	Noncontrolling Interests and Redeemable Noncontrolling Interests The ownership interests held by owners other than the Company in less than wholly-owned subsidiaries are classified as noncontrolling interests. The financial results and position of noncontrolling interests are included in the Company’s unaudited condensed consolidated financial statements. The value attributable to the noncontrolling interests is presented on the unaudited condensed consolidated balance sheets, separately from the equity attributable to the Company. Net income (loss) and comprehensive income (loss) attributable to noncontrolling interests are presented separately on the unaudited condensed consolidated statements of operations and unaudited condensed consolidated statements of comprehensive income, respectively.
Cash, Cash Equivalents and Restricted Cash	Cash, Cash Equivalents and Restricted Cash
Foreign Currency Transactions	Foreign Currency Transactions Foreign currency transaction losses included in selling, general and administrative expenses were less than $0.1 million and $0.9 million for the three months ended September 30, 2024 and 2023, respectively. Foreign currency transaction losses included in selling, general and administrative expenses were $1.0 million and $3.4 million for the nine months ended September 30, 2024 and 2023, respectively.
Recently Issued Accounting Standards	Recently Issued Accounting Standards In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-07, "Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures." The amendments in this update improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact this standard will have on its consolidated financial statements and related disclosures. In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740) - Improvements to Income Tax Disclosures."

Allowance for Doubtful Accoun_2

Allowance for Doubtful Accounts (Tables)	9 Months Ended
	Sep. 30, 2024
Receivables [Abstract]
Schedule of Activity Related to the Allowance for Doubtful Accounts	The activity related to the allowance for doubtful accounts was as follows: Three months ended September 30, Nine months ended September 30, (in thousands) 2024 2023 2024 2023 Balance at beginning of period $ 9,123 $ 9,008 $ 8,840 $ 8,258 Bad debt (recovery) expense (207) 17 444 814 Amount of receivables written off (247) (239) (492) (341) Foreign currency translation 246 (124) 123 (69) Balance at end of period $ 8,915 $ 8,662 $ 8,915 $ 8,662

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2024
Inventory Disclosure [Abstract]
Schedule of Inventories	The components of inventories were as follows: September 30, December 31, (in thousands) 2024 2023 Raw materials and supplies $ 133,944 $ 157,455 Work-in-process 28,027 24,949 Finished goods 335,548 433,131 Inventories $ 497,519 $ 615,535

Product Warranty (Tables)

Product Warranty (Tables)	9 Months Ended
	Sep. 30, 2024
Product Warranties Disclosures [Abstract]
Schedule of Warranty Obligation for Accrued Warranty Expense	The activity related to the Company’s warranty obligation for accrued warranty expense was as follows: Three months ended September 30, Nine months ended September 30, (in thousands) 2024 2023 2024 2023 Balance at beginning of period $ 5,511 $ 5,049 $ 4,997 $ 3,951 Provision 1,325 1,568 5,123 5,313 Claims paid/costs incurred (1,511) (1,685) (4,708) (4,337) Foreign currency translation 83 (61) (4) (56) Balance at end of period $ 5,408 $ 4,871 $ 5,408 $ 4,871

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Values of Hedge Instruments on the Unaudited Condensed Consolidated Balance Sheets	The fair value of hedge instruments recognized on the unaudited condensed consolidated balance sheets was as follows: (in thousands) September 30, December 31, Balance Sheet Location Hedge Instrument Type 2024 2023 Prepaid and other assets Foreign exchange forward $ 1,912 $ 4,378 Interest rate swap 79 452 Accrued expenses and other liabilities Foreign exchange forward 5,246 1,931 Interest rate swap 40 63 Other noncurrent liabilities Foreign exchange forward 19 — Interest rate swap — 88
Schedule of Effect of Hedge Instruments Losses on Accumulated Other Comprehensive Loss, Net of Tax	The hedge instrument (losses) gains recognized in accumulated other comprehensive loss, net of tax was as follows: Three months ended Nine months ended September 30, September 30, (in thousands) 2024 2023 2024 2023 Type of hedge Foreign exchange forward $ (3,635) $ 3,658 $ 1,702 $ 6,719 Interest rate swap (258) 432 511 1,601 Total $ (3,893) $ 4,090 $ 2,213 $ 8,320
Schedule of Effect of Hedge Instrument in the Unaudited Condensed Consolidated Statement of Operations	The hedge instrument gains (losses) recognized on the unaudited condensed consolidated statements of operations were as follows: Three months ended Nine months ended September 30, September 30, (in thousands) 2024 2023 2024 2023 Location of gains (losses) in statements of operations Foreign exchange forward: Cost of goods sold $ 3,040 $ 682 $ 8,443 $ 6,975 Selling, general and administrative (1) (1,634) 1,106 (253) 1,463 Total $ 1,406 $ 1,788 $ 8,190 $ 8,438 Interest Rate Swap: Interest expense, net $ 256 $ 241 $ 773 $ 429 Total $ 256 $ 241 $ 773 $ 429 _______________________________________________________________________________ (1)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis	Assets and liabilities measured at fair value on a recurring basis as of September 30, 2024 were as follows: Fair Value Measurements as of September 30, 2024 using: (in thousands) Level 1 Level 2 Level 3 Balance Sheet Location Assets Rabbi trust $ 3,142 $ — $ — Prepaid and other assets Foreign exchange derivative instruments — 1,912 — Prepaid and other assets Interest rate derivative instruments — 79 — Prepaid and other assets Deferred compensation program assets 622 — — Other assets Total assets $ 3,764 $ 1,991 $ — Liabilities Foreign exchange derivative instruments $ — $ 5,246 $ — Accrued expenses and other liabilities Interest rate derivative instruments — 40 — Accrued expenses and other liabilities Deferred compensation program liabilities 622 — — Other noncurrent liabilities Foreign exchange derivative instruments — 19 — Other noncurrent liabilities Total liabilities $ 622 $ 5,305 $ — Assets and liabilities measured at fair value on a recurring basis as of December 31, 2023 were as follows: Fair Value Measurements as of December 31, 2023 using: (in thousands) Level 1 Level 2 Level 3 Balance Sheet Location Assets Rabbi trust $ 4,334 $ — $ — Prepaid and other assets Foreign exchange derivative instruments — 4,378 — Prepaid and other assets Interest rate derivative instruments — 452 — Prepaid and other assets Deferred compensation program assets 725 — — Other assets Total assets $ 5,059 $ 4,830 $ — Liabilities Foreign exchange derivative instruments $ — $ 1,931 $ — Accrued expenses and other liabilities Interest rate derivative instruments — 63 — Accrued expenses and other liabilities Deferred compensation program liabilities 725 — — Other noncurrent liabilities Interest rate derivative instruments — 88 — Other noncurrent liabilities Total liabilities $ 725 $ 2,082 $ —

Pension and Other Postretirem_2

Pension and Other Postretirement Benefits (Tables)	9 Months Ended
	Sep. 30, 2024
Retirement Benefits [Abstract]
Schedule of Components of Net Periodic Benefit Cost (Credit)	Components of net periodic benefit cost (credit) were as follows: Pension Benefits Postretirement Benefits Three months ended September 30, (in thousands) 2024 2023 2024 2023 Components of net periodic benefit cost (credit) Service cost $ 1,327 $ 1,411 $ 84 $ 107 Interest cost 2,645 2,832 129 166 Expected return on plan assets (1,838) (1,966) — — Settlements 142 — — — Amortization of net loss (gain) 60 25 (252) (223) Amortization of prior service cost (credit) 24 45 (35) (35) Net periodic benefit cost (credit) $ 2,360 $ 2,347 $ (74) $ 15 Pension Benefits Postretirement Benefits Nine months ended September 30, (in thousands) 2024 2023 2024 2023 Components of net periodic benefit cost (credit) Service cost $ 3,958 $ 4,261 $ 250 $ 322 Interest cost 8,033 8,491 389 497 Expected return on plan assets (5,510) (5,894) — — Settlements 142 (27) — — Amortization of net loss (gain) 177 70 (760) (670) Amortization of prior service cost (credit) 70 137 (103) (103) Net periodic benefit cost (credit) $ 6,870 $ 7,038 $ (224) $ 46

Common Stock (Tables)

Common Stock (Tables)	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Schedule of Declared Dividends Per Share	The Company declared dividends per common share, including DERs (Note 11), during the periods presented as follows: Dividends per Common Share Amount (in thousands) 2024: Third Quarter $ 0.215 $ 13,787 Second Quarter 0.215 13,873 First Quarter 0.215 14,155 Total dividends declared in 2024 $ 0.645 $ 41,815 2023: Fourth Quarter $ 0.195 $ 12,941 Third Quarter 0.195 13,098 Second Quarter 0.195 13,667 First Quarter 0.195 13,629 Total dividends declared in 2023 $ 0.780 $ 53,335
Schedule of Share Repurchase Activity	The Company's share repurchase activity for the periods presented was as follows: Three months ended September 30, Nine months ended September 30, (in thousands, except share and per share amounts) 2024 2023 2024 2023 Shares repurchased in the open market: Shares repurchased 493,040 1,153,400 1,627,793 1,982,289 Average price $ 65.96 $ 56.28 $ 64.70 $ 52.98 Aggregate value $ 32,522 $ 64,918 $ 105,323 $ 105,030 Shares repurchased from Magnus: Shares repurchased 587,520 — 587,520 2,168,528 Average price (1) $ 63.83 $ — $ 63.83 $ 46.11 Aggregate value $ 37,499 $ — $ 37,499 $ 100,001 Total shares repurchased: Shares repurchased 1,080,560 1,153,400 2,215,313 4,150,817 Average price $ 64.80 $ 56.28 $ 64.47 $ 49.40 Aggregate value (2) $ 70,021 $ 64,918 $ 142,822 $ 205,031 ___________________________________ (1) In accordance with the share repurchase agreements, shares purchased from Magnus are accrued for at the same weighted average price as those purchased on the open market, as if the purchase from Magnus had occurred on the same day. As such, the average price of Magnus repurchases during any given period will differ from open market repurchases due to the settlement of the previously recorded share repurchase liability, as well as open market purchases made after the completion of the Magnus share repurchase agreements. (2)

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	9 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Restricted and Performance Stock Units	A summary of the Company’s RSUs and PSUs as of September 30, 2024 and changes during the nine months then ended is presented below: Weighted- Weighted- Number Average Number Average of RSUs Fair Value RSUs of PSUs (3) Fair Value PSUs Outstanding as of December 31, 2023 868,063 $ 46.45 480,254 $ 46.07 Granted 309,293 66.70 156,087 66.77 Vested (1)(2) (492,950) 46.51 (133,099) 45.36 Forfeited (20,635) 36.42 (2,275) 56.40 Outstanding as of September 30, 2024 663,771 $ 56.16 500,967 $ 52.66 _______________________________________________________________________________ (1) Includes 54,117 shares of common stock related to RSU's that were not delivered as of September 30, 2024. (2) Based upon the Company’s level of achievement of the applicable performance metrics, the recipients of the 133,099 PSUs that vested during the nine months ended September 30, 2024, were entitled to receive 266,198 shares of common stock. As of September 30, 2024, there were 86,762 shares of common stock that had not been delivered in connection with the vesting of these PSUs. (3) Number of PSUs reflects 100% of the target level grant and may not be indicative of the performance level expected to be achieved.
Schedule of Shares of Common Stock Issued	Compensation expense recorded related to the Company's RSUs and PSUs in the unaudited condensed consolidated statements of operations was as follows: Three months ended Nine months ended September 30, September 30, (in thousands) 2024 2023 2024 2023 RSUs $ 4,505 $ 4,012 $ 14,633 $ 12,966 PSUs 4,378 1,129 8,889 7,911 A summary of shares of common stock issued related to the 2015 Plan, including the impact of any DERs issued in common stock, is presented below: Nine months ended Nine months ended September 30, 2024 September 30, 2023 RSUs PSUs RSUs PSUs Shares of common stock issued 477,642 219,831 472,766 231,580 Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations (159,600) (95,814) (128,291) (91,842) Net shares of common stock issued 318,042 124,017 344,475 139,738 Cumulative undelivered shares of common stock 480,608 471,078 457,703 420,447
Schedule of Compensation Expense Related to Equity Incentive Plans	The allocation of share-based compensation expense in the unaudited condensed consolidated statements of operations was as follows: Three months ended Nine months ended September 30, September 30, (in thousands) 2024 2023 2024 2023 Cost of goods sold $ 439 $ 340 $ 1,242 $ 1,095 Selling, general and administrative 8,207 4,629 21,524 18,875 Research and development 385 336 1,232 1,399 Total compensation expense before income tax 9,031 5,305 23,998 21,369 Income tax benefit 2,024 945 5,433 4,304 Total compensation expense, net of income tax $ 7,007 $ 4,360 $ 18,565 $ 17,065

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss, Net of Tax (Tables)	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Schedule of Changes in Each Component of Accumulated Comprehensive Loss, Net of Tax Effects	The components of and adjustments to accumulated other comprehensive loss, net of tax, were as follows: Foreign Interest Accumulated Foreign Exchange Rate Swap Pension and Other Currency Derivative Derivative Other Comprehensive (in thousands) Translation Instruments Instruments Postretirement Loss, Net of Tax Balance as of December 31, 2023 $ (95,425) $ 3,929 $ 227 $ (13,080) $ (104,349) Other comprehensive income (loss) before reclassifications 1,603 1,702 511 (320) 3,496 Amounts reclassified from accumulated other comprehensive loss, net of tax — (8,443) (773) (474) (9,690) Tax benefit — 2,205 64 175 2,444 Balance as of September 30, 2024 $ (93,822) $ (607) $ 29 $ (13,699) $ (108,099)

Net Income per Common Share (Ta

Net Income per Common Share (Tables)	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Net Income Per Common Share	The following is a computation of basic and diluted net income per common share attributable to Acushnet Holdings Corp.: Three months ended Nine months ended September 30, September 30, (in thousands, except share and per share amounts) 2024 2023 2024 2023 Net income attributable to Acushnet Holdings Corp. $ 56,224 $ 57,307 $ 215,414 $ 225,237 Weighted average number of common shares: Basic 62,894,940 66,898,142 63,813,805 67,812,790 RSUs 200,837 328,411 214,899 290,274 PSUs 75,959 116,707 41,796 104,958 Diluted 63,171,736 67,343,260 64,070,500 68,208,022 Net income per common share attributable to Acushnet Holdings Corp.: Basic $ 0.89 $ 0.86 $ 3.38 $ 3.32 Diluted $ 0.89 $ 0.85 $ 3.36 $ 3.30
Schedule of Securities Excluded From the Calculation of Diluted Weighted Average Common Shares	The following securities have been excluded from the calculation of diluted weighted-average common shares outstanding as their impact was determined to be anti-dilutive: Three months ended Nine months ended September 30, September 30, 2024 2023 2024 2023 RSUs 201,512 — 212,224 86,499

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Schedule of Information by Reportable Segment and a Reconciliation to Reported Amounts	Information by reportable segment and a reconciliation to reported amounts are as follows: Three months ended September 30, Nine months ended September 30, (in thousands) 2024 2023 2024 2023 Net sales Titleist golf balls $ 190,560 $ 192,557 $ 646,017 $ 622,125 Titleist golf clubs 213,907 181,045 595,311 549,846 Titleist golf gear 51,574 47,657 188,661 184,571 FootJoy golf wear 133,137 136,669 482,753 500,174 Other 31,323 35,453 99,180 112,318 Total net sales $ 620,501 $ 593,381 $ 2,011,922 $ 1,969,034 Segment operating income Titleist golf balls $ 31,150 $ 43,770 $ 134,334 $ 131,591 Titleist golf clubs 49,930 36,509 124,670 118,455 Titleist golf gear 4,246 788 28,270 26,657 FootJoy golf wear 502 (1,469) 34,814 32,927 Other 804 1,693 7,348 12,606 Total segment operating income 86,632 81,291 329,436 322,236 Reconciling items: Interest expense, net (13,187) (9,389) (40,367) (30,234) Non-service cost component of net periodic benefit cost (875) (844) (2,438) (2,501) Other (1) (4,097) (2,760) (18,816) (11,746) Total income before income tax $ 68,473 $ 68,298 $ 267,815 $ 277,755 _______________________________________________________________________________ (1) For the nine months ended September 30, 2024, includes $7.0 million related to restructuring costs associated with the closure of certain production lines at the VIE's Fujian Fuh Deh Leh (“FDL”) factory (Note 16).
Schedule of Net Sales By Geographical Area	Information as to the Company’s operations in different geographical areas is presented below. Net sales are categorized based on the location in which the sale originates. Three months ended September 30, Nine months ended September 30, (in thousands) 2024 2023 2024 2023 United States $ 374,219 $ 352,463 $ 1,200,989 $ 1,123,766 EMEA (1) 75,496 75,643 263,850 266,502 Japan 41,738 39,035 108,731 118,183 Korea 67,091 65,652 226,167 241,267 Rest of World 61,957 60,588 212,185 219,316 Total net sales $ 620,501 $ 593,381 $ 2,011,922 $ 1,969,034 _______________________________________________________________________________ (1) Europe, the Middle East and Africa ("EMEA")

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Purchase Obligations	The Company's purchase obligations as of September 30, 2024 were as follows: Payments Due by Period Remainder of (in thousands) 2024 2025 2026 2027 2028 Thereafter Purchase obligations (1) $ 237,533 $ 62,158 $ 5,392 $ 2,483 $ 2,417 $ 7,240 _______________________________________________________________________________ (1) The reported amounts exclude those liabilities included in accounts payable or accrued liabilities on the unaudited condensed consolidated balance sheet as of September 30, 2024.

Restructuring Costs (Tables)

Restructuring Costs (Tables)	9 Months Ended
	Sep. 30, 2024
Restructuring and Related Activities [Abstract]
Schedule of Company's Restructuring Programs	The activity related to the Plan was as follows: (in thousands) Three months ended September 30, 2024 Nine months ended September 30, 2024 Balance at beginning of period $ 2,013 $ — Provision — 6,967 Payments (386) (5,340) Balance at end of period $ 1,627 $ 1,627

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Variable Interest Entity [Line Items]
Redemption value adjustment			$ 1,000,000
Loan to minority shareholders included in temporary equity	$ 4,400,000		4,400,000		$ 4,400,000
Restricted cash	1,700,000		1,700,000		1,700,000
Retained Earnings
Variable Interest Entity [Line Items]
Redemption value adjustment			1,000,000
Selling, general and administrative
Variable Interest Entity [Line Items]
Transaction losses included in selling, general and administrative expense	100,000	$ 900,000	$ 1,000,000	$ 3,400,000
VIE
Variable Interest Entity [Line Items]
Ownership percentage			40%
Outstanding borrowings	$ 0		$ 0		$ 0

Allowance for Doubtful Accoun_3

Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance at beginning of period	$ 9,123	$ 9,008	$ 8,840	$ 8,258
Bad debt (recovery) expense	(207)	17	444	814
Amount of receivables written off	(247)	(239)	(492)	(341)
Foreign currency translation	246	(124)	123	(69)
Balance at end of period	$ 8,915	$ 8,662	$ 8,915	$ 8,662

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Raw materials and supplies	$ 133,944	$ 157,455
Work-in-process	28,027	24,949
Finished goods	335,548	433,131
Inventories	$ 497,519	$ 615,535

Product Warranty (Details)

Product Warranty (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Activity for accrued warranty expense
Balance at beginning of period	$ 5,511	$ 5,049	$ 4,997	$ 3,951
Provision	1,325	1,568	5,123	5,313
Claims paid/costs incurred	(1,511)	(1,685)	(4,708)	(4,337)
Foreign currency translation	83	(61)	(4)	(56)
Balance at end of period	$ 5,408	$ 4,871	$ 5,408	$ 4,871
Minimum
Product Warranty Liability [Line Items]
Product warranty period			1 year
Maximum
Product Warranty Liability [Line Items]
Product warranty period			2 years

Debt and Financing Arrangemen_2

Debt and Financing Arrangements (Details) - USD ($)			9 Months Ended	12 Months Ended
	Jun. 28, 2024	Oct. 03, 2023	Sep. 30, 2024	Dec. 31, 2023	Aug. 02, 2022
Unsecured Local Credit Facilities
Line of Credit Facility [Line Items]
Weighted average interest rate (as percent)			0.59%	0.45%
Available borrowings			$ 41,500,000
Other short-term borrowings, outstanding borrowings			21,200,000	$ 29,000,000
Senior Unsecured Notes due 2028 | Unsecured Local Credit Facilities
Line of Credit Facility [Line Items]
Amount outstanding		$ 350,000,000
Debt instrument interest rate stated percentage		7.375%
Incurred fees and expenses		$ 6,400,000
Debt issuance costs		$ 6,300,000
Effective interest rate		7.813%
Accrued interest			12,000,000	6,500,000
Senior Unsecured Notes due 2028 | Unsecured Local Credit Facilities | Level 2
Line of Credit Facility [Line Items]
Fair value of notes			366,600,000	365,100,000
Revolving Credit Facility
Line of Credit Facility [Line Items]
Maximum borrowing capacity					$ 950,000,000
Outstanding borrowings			$ 359,400,000	$ 325,200,000
Weighted average interest rate (as percent)			6.16%	6.57%
Available borrowings			$ 586,700,000
Letters of credit outstanding			3,900,000
Revolving Credit Facility | Unsecured Local Credit Facilities
Line of Credit Facility [Line Items]
Outstanding borrowings		$ 345,600,000
Line of Credit | Minimum | Canadian Overnight Repo Rate Average
Line of Credit Facility [Line Items]
Variable rate of interest	0.29547%
Line of Credit | Minimum | Adjusted Term Canadian Overnight Repo Rate Average
Line of Credit Facility [Line Items]
Variable rate of interest	1%
Line of Credit | Maximum | Canadian Overnight Repo Rate Average
Line of Credit Facility [Line Items]
Variable rate of interest	0.32138%
Line of Credit | Maximum | Adjusted Term Canadian Overnight Repo Rate Average
Line of Credit Facility [Line Items]
Variable rate of interest	1.75%
Letters of Credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity			58,400,000
Outstanding borrowings			7,000,000	$ 11,300,000
Line of credit secured			$ 3,900,000	$ 8,100,000

Derivative Financial Instrume_3

Derivative Financial Instruments - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Foreign exchange forward
Derivatives, Fair Value [Line Items]
Expected reclassification of net gain (loss) recorded in accumulated other comprehensive gain (loss), net of tax into cost of goods sold during next twelve months	$ 0.3
Foreign exchange forward | Derivative Designated As Hedging
Derivatives, Fair Value [Line Items]
Notional amount	$ 234.3	$ 209.6
Foreign exchange forward | Maximum
Derivatives, Fair Value [Line Items]
Term of derivative contract (in months)	24 months
Interest rate swap
Derivatives, Fair Value [Line Items]
Expected reclassification of net gain (loss) recorded in accumulated other comprehensive gain (loss), net of tax into cost of goods sold during next twelve months	$ 0.1
Interest rate swap | Derivative Designated As Hedging
Derivatives, Fair Value [Line Items]
Notional amount	$ 100	$ 100

Derivative Financial Instrume_4

Derivative Financial Instruments - Schedule of Fair Values of Hedge Instruments on the Unaudited Condensed Consolidated Balance Sheets (Details) - Derivative Designated As Hedging - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Foreign exchange forward | Prepaid and other assets
Derivatives, Fair Value [Line Items]
Asset derivatives	$ 1,912	$ 4,378
Foreign exchange forward | Accrued expenses and other liabilities
Derivatives, Fair Value [Line Items]
Liability derivatives	5,246	1,931
Foreign exchange forward | Other noncurrent liabilities
Derivatives, Fair Value [Line Items]
Liability derivatives	19	0
Interest rate swap | Prepaid and other assets
Derivatives, Fair Value [Line Items]
Asset derivatives	79	452
Interest rate swap | Accrued expenses and other liabilities
Derivatives, Fair Value [Line Items]
Liability derivatives	40	63
Interest rate swap | Other noncurrent liabilities
Derivatives, Fair Value [Line Items]
Liability derivatives	$ 0	$ 88

Derivative Financial Instrume_5

Derivative Financial Instruments - Schedule of Effect of Hedge Instruments on Accumulated Other Comprehensive Loss, Net of Tax (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Total	$ (3,893)	$ 4,090	$ 2,213	$ 8,320
Cash Flow Hedge | Derivative Designated As Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Total	(3,893)	4,090	2,213	8,320
Foreign exchange forward | Cash Flow Hedge | Derivative Designated As Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Total	(3,635)	3,658	1,702	6,719
Interest rate swap | Cash Flow Hedge | Derivative Designated As Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Total	$ (258)	$ 432	$ 511	$ 1,601

Derivative Financial Instrume_6

Derivative Financial Instruments - Schedule of Effect of Hedge Instrument in the Unaudited Condensed Consolidated Statement of Operations (Details) - Derivative Designated As Hedging - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Foreign exchange forward
Derivative Instruments, Gain (Loss) [Line Items]
Gain recognized on unaudited condensed consolidated statements of operations	$ 1,406	$ 1,788	$ 8,190	$ 8,438
Foreign exchange forward | Cost of goods sold
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of goods sold	Cost of goods sold	Cost of goods sold	Cost of goods sold
Gain recognized on unaudited condensed consolidated statements of operations	$ 3,040	$ 682	$ 8,443	$ 6,975
Foreign exchange forward | Selling, general and administrative
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Selling, general and administrative	Selling, general and administrative	Selling, general and administrative	Selling, general and administrative
Gain recognized on unaudited condensed consolidated statements of operations	$ (1,634)	$ 1,106	$ (253)	$ 1,463
Interest rate swap
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Interest expense, net	Interest expense, net	Interest expense, net	Interest expense, net
Gain recognized on unaudited condensed consolidated statements of operations	$ 256	$ 241	$ 773	$ 429

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Level 1
Assets
Rabbi trust	$ 3,142	$ 4,334
Deferred compensation program assets	622	725
Total assets	3,764	5,059
Liabilities
Deferred compensation program liabilities	622	725
Total liabilities	622	725
Level 1 | Foreign exchange derivative instruments
Assets
Foreign exchange derivative instruments	0	0
Liabilities
Derivative instruments, current	0	0
Derivative instruments, noncurrent	0
Level 1 | Interest rate derivative instruments
Assets
Interest rate derivative instruments	0	0
Liabilities
Derivative instruments, current	0	0
Derivative instruments, noncurrent		0
Level 2
Assets
Rabbi trust	0	0
Deferred compensation program assets	0	0
Total assets	1,991	4,830
Liabilities
Deferred compensation program liabilities	0	0
Total liabilities	5,305	2,082
Level 2 | Foreign exchange derivative instruments
Assets
Foreign exchange derivative instruments	1,912	4,378
Liabilities
Derivative instruments, current	5,246	1,931
Derivative instruments, noncurrent	19
Level 2 | Interest rate derivative instruments
Assets
Interest rate derivative instruments	79	452
Liabilities
Derivative instruments, current	40	63
Derivative instruments, noncurrent		88
Level 3
Assets
Rabbi trust	0	0
Deferred compensation program assets	0	0
Total assets	0	0
Liabilities
Deferred compensation program liabilities	0	0
Total liabilities	0	0
Level 3 | Foreign exchange derivative instruments
Assets
Foreign exchange derivative instruments	0	0
Liabilities
Derivative instruments, current	0	0
Derivative instruments, noncurrent	0
Level 3 | Interest rate derivative instruments
Assets
Interest rate derivative instruments	0	0
Liabilities
Derivative instruments, current	$ 0	0
Derivative instruments, noncurrent		$ 0

Pension and Other Postretirem_3

Pension and Other Postretirement Benefits (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pension Benefits
Components of net periodic benefit cost (credit)
Service cost	$ 1,327	$ 1,411	$ 3,958	$ 4,261
Interest cost	2,645	2,832	8,033	8,491
Expected return on plan assets	(1,838)	(1,966)	(5,510)	(5,894)
Settlements	142	0	142	(27)
Amortization of net loss (gain)	60	25	177	70
Amortization of prior service cost (credit)	24	45	70	137
Net periodic benefit cost (credit)	2,360	2,347	6,870	7,038
Postretirement Benefits
Components of net periodic benefit cost (credit)
Service cost	84	107	250	322
Interest cost	129	166	389	497
Expected return on plan assets	0	0	0	0
Settlements	0	0	0	0
Amortization of net loss (gain)	(252)	(223)	(760)	(670)
Amortization of prior service cost (credit)	(35)	(35)	(103)	(103)
Net periodic benefit cost (credit)	$ (74)	$ 15	$ (224)	$ 46

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Increase in income tax expense	$ 1,900		$ 5,100
Income tax expense	$ 13,198	$ 11,252	$ 57,817	$ 52,726
Effective tax rate (as percent)	19.30%	16.50%	21.60%	19%

Common Stock - Schedule of Decl

Common Stock - Schedule of Declared Dividends Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended							9 Months Ended		12 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Equity [Abstract]
Dividends per Common Share (in dollars per share)	$ 0.215	$ 0.215	$ 0.215	$ 0.195	$ 0.195	$ 0.195	$ 0.195	$ 0.645		$ 0.780
Amount	$ 13,787	$ 13,873	$ 14,155	$ 12,941	$ 13,098	$ 13,667	$ 13,629	$ 41,815	$ 40,394	$ 53,335

Common Stock - Narrative (Detai

Common Stock - Narrative (Details) - USD ($)					1 Months Ended	3 Months Ended							9 Months Ended		12 Months Ended
	Jul. 10, 2024	Nov. 03, 2023	Jan. 23, 2023	Jan. 13, 2023	Nov. 07, 2024	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Jun. 14, 2024	Mar. 14, 2024	Jun. 09, 2023	Dec. 31, 2022	Aug. 30, 2022	Jun. 16, 2022
Dividends Payable [Line Items]
Dividends per Common Share (in dollars per share)						$ 0.215	$ 0.215	$ 0.215	$ 0.195	$ 0.195	$ 0.195	$ 0.195	$ 0.645		$ 0.780
Issued and outstanding common stock authorized to repurchase						$ 1,000,000,000							$ 1,000,000,000
Shares repurchased (in shares)						1,080,560				1,153,400			2,215,313	4,150,817
Aggregate value						$ 70,021,000				$ 64,918,000			$ 142,822,000	$ 205,031,000
Satisfaction of obligation under agreement						232,200,000							232,200,000
Subsequent Event
Dividends Payable [Line Items]
Dividends per Common Share (in dollars per share)					$ 0.215
Magnus
Dividends Payable [Line Items]
Issued and outstanding common stock authorized to repurchase																				$ 100,000,000	$ 75,000,000
Share repurchase liability						$ 32,500,000							$ 32,500,000						$ 92,600,000
Accrued share repurchase (in shares)	587,520					493,040							493,040						2,000,839
Shares repurchased (in shares)		1,824,994	2,168,528			587,520				0			587,520	2,168,528
Aggregate value	$ 37,500,000	$ 100,000,000	$ 100,000,000			$ 37,499,000				$ 0			$ 37,499,000	$ 100,001,000
Stock repurchase program, authorized amount						$ 62,500,000							$ 62,500,000			$ 62,500,000	$ 37,500,000	$ 100,000,000
Open Market
Dividends Payable [Line Items]
Shares repurchased (in shares)				167,689		493,040				1,153,400			1,627,793	1,982,289
Aggregate value				$ 7,400,000		$ 32,522,000				$ 64,918,000			$ 105,323,000	$ 105,030,000
Aggregate purchases of shares in open market before shares will be purchased from Magnus						$ 100,000,000							100,000,000
Open Market | Common Stock
Dividends Payable [Line Items]
Aggregate value													$ 143,600,000
Common stock presented and retired (in shares)													2,215,313

Common Stock - Schedule of Shar

Common Stock - Schedule of Share Repurchase Activity (Details) - USD ($) $ / shares in Units, $ in Thousands					3 Months Ended		9 Months Ended
	Jul. 10, 2024	Nov. 03, 2023	Jan. 23, 2023	Jan. 13, 2023	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Dividends Payable [Line Items]
Shares repurchased (in shares)					1,080,560	1,153,400	2,215,313	4,150,817
Average price (in dollars per share)					$ 64.80	$ 56.28	$ 64.47	$ 49.40
Aggregate value					$ 70,021	$ 64,918	$ 142,822	$ 205,031
Open Market
Dividends Payable [Line Items]
Shares repurchased (in shares)				167,689	493,040	1,153,400	1,627,793	1,982,289
Average price (in dollars per share)					$ 65.96	$ 56.28	$ 64.70	$ 52.98
Aggregate value				$ 7,400	$ 32,522	$ 64,918	$ 105,323	$ 105,030
Excise tax accrued					800		800
Treasury stock, value repurchased not settled					$ 500	$ 2,000	$ 500	$ 2,000
Magnus
Dividends Payable [Line Items]
Shares repurchased (in shares)		1,824,994	2,168,528		587,520	0	587,520	2,168,528
Average price (in dollars per share)					$ 63.83	$ 0	$ 63.83	$ 46.11
Aggregate value	$ 37,500	$ 100,000	$ 100,000		$ 37,499	$ 0	$ 37,499	$ 100,001

Equity Incentive Plans - Narrat

Equity Incentive Plans - Narrative (Details) $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($)
RSUs | 2015 Omnibus Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense	$ 25.3
Weighted average period (in years)	1 year 4 months 24 days
RSUs | Company Officers
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)	3 years
Vesting percentage	33.33%
RSUs | Officers, Employees, Consultants and Advisors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)	3 years
RSUs | Other Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	33.33%
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance period (in years)	3 years
PSUs | 2015 Omnibus Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense	$ 16.5
Weighted average period (in years)	1 year 10 months 24 days
PSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	0%
PSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	200%

Equity Incentive Plans - Schedu

Equity Incentive Plans - Schedule of Restricted and Performance Stock Units (Details) - 2015 Omnibus Incentive Plan	9 Months Ended
	Sep. 30, 2024 $ / shares shares
Common Stock
Weighted - Average Fair Value
Undelivered (in shares)	266,198
RSUs
Number of Units
Outstanding at beginning of the period (in shares)	868,063
Granted (in shares)	309,293
Vested (in shares)	(492,950)
Forfeited (in shares)	(20,635)
Outstanding at end of the period (in shares)	663,771
Weighted - Average Fair Value
Outstanding at beginning of the period (in dollars per share) | $ / shares	$ 46.45
Granted (in dollars per share) | $ / shares	66.70
Vested (in dollars per share) | $ / shares	46.51
Forfeited (in dollars per share) | $ / shares	36.42
Outstanding at end of the period (in dollars per share) | $ / shares	$ 56.16
Undelivered (in shares)	54,117
PSUs
Number of Units
Outstanding at beginning of the period (in shares)	480,254
Granted (in shares)	156,087
Vested (in shares)	(133,099)
Forfeited (in shares)	(2,275)
Outstanding at end of the period (in shares)	500,967
Weighted - Average Fair Value
Outstanding at beginning of the period (in dollars per share) | $ / shares	$ 46.07
Granted (in dollars per share) | $ / shares	66.77
Vested (in dollars per share) | $ / shares	45.36
Forfeited (in dollars per share) | $ / shares	56.40
Outstanding at end of the period (in dollars per share) | $ / shares	$ 52.66
Undelivered (in shares)	86,762
Achieved target level of performance (in percent)	100%

Equity Incentive Plans - Sche_2

Equity Incentive Plans - Schedule of Compensation Expense Recorded in the Consolidated Statement of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation expense	$ 9,031	$ 5,305	$ 23,998	$ 21,369
RSUs | 2015 Omnibus Incentive Plan
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation expense	4,505	4,012	14,633	12,966
PSUs | 2015 Omnibus Incentive Plan
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Compensation expense	$ 4,378	$ 1,129	$ 8,889	$ 7,911

Equity Incentive Plans - Sche_3

Equity Incentive Plans - Schedule of Shares of Common Stock Issued (Details) - 2015 Omnibus Incentive Plan - shares	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
RSUs
Class of Stock [Line Items]
Cumulative undelivered shares of common stock (in shares)	54,117
PSUs
Class of Stock [Line Items]
Cumulative undelivered shares of common stock (in shares)	86,762
Common Stock | RSUs
Class of Stock [Line Items]
Shares of common stock issued (in shares)	477,642	472,766
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations (in shares)	(159,600)	(128,291)
Net shares of common stock issued (in shares)	318,042	344,475
Cumulative undelivered shares of common stock (in shares)	480,608	457,703
Common Stock | PSUs
Class of Stock [Line Items]
Shares of common stock issued (in shares)	219,831	231,580
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations (in shares)	(95,814)	(91,842)
Net shares of common stock issued (in shares)	124,017	139,738
Cumulative undelivered shares of common stock (in shares)	471,078	420,447

Equity Incentive Plans - Sche_4

Equity Incentive Plans - Schedule of Compensation Expense Related to Equity Incentive Plans (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total compensation expense before income tax	$ 9,031	$ 5,305	$ 23,998	$ 21,369
Income tax benefit	2,024	945	5,433	4,304
Total compensation expense, net of income tax	7,007	4,360	18,565	17,065
Cost of goods sold
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total compensation expense before income tax	439	340	1,242	1,095
Selling, general and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total compensation expense before income tax	8,207	4,629	21,524	18,875
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total compensation expense before income tax	$ 385	$ 336	$ 1,232	$ 1,399

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss, Net of Tax (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2024 USD ($)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 903,087
Other comprehensive income (loss) before reclassifications	3,496
Amounts reclassified from accumulated other comprehensive loss, net of tax	(9,690)
Tax benefit	2,444
Ending balance	898,602
Foreign Currency Translation
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(95,425)
Other comprehensive income (loss) before reclassifications	1,603
Amounts reclassified from accumulated other comprehensive loss, net of tax	0
Tax benefit	0
Ending balance	(93,822)
Gains (Losses) on Derivative Instruments | Foreign Exchange Derivative Instruments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	3,929
Other comprehensive income (loss) before reclassifications	1,702
Amounts reclassified from accumulated other comprehensive loss, net of tax	(8,443)
Tax benefit	2,205
Ending balance	(607)
Gains (Losses) on Derivative Instruments | Interest rate swap
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	227
Other comprehensive income (loss) before reclassifications	511
Amounts reclassified from accumulated other comprehensive loss, net of tax	(773)
Tax benefit	64
Ending balance	29
Pension and Other Postretirement
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(13,080)
Other comprehensive income (loss) before reclassifications	(320)
Amounts reclassified from accumulated other comprehensive loss, net of tax	(474)
Tax benefit	175
Ending balance	(13,699)
Accumulated Other Comprehensive Loss, Net of Tax
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(104,349)
Ending balance	$ (108,099)

Net Income per Common Share - S

Net Income per Common Share - Schedule of Computation of Basic and Diluted Net Income Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net income attributable to Acushnet Holdings Corp.	$ 56,224	$ 57,307	$ 215,414	$ 225,237
Weighted average number of common shares:
Basic (in shares)	62,894,940	66,898,142	63,813,805	67,812,790
Diluted (in shares)	63,171,736	67,343,260	64,070,500	68,208,022
Net income per common share attributable to Acushnet Holdings Corp.:
Basic (in dollars per share)	$ 0.89	$ 0.86	$ 3.38	$ 3.32
Diluted (in dollars per share)	$ 0.89	$ 0.85	$ 3.36	$ 3.30
RSUs
Weighted average number of common shares:
Basic (in shares)	200,837	328,411	214,899	290,274
PSUs
Weighted average number of common shares:
Basic (in shares)	75,959	116,707	41,796	104,958

Net Income per Common Share -_2

Net Income per Common Share - Schedule of Securities Excluded From the Calculation of Diluted Weighted Average Common Shares (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of earnings per share (in shares)	201,512	0	212,224	86,499

Segment Information - Schedule

Segment Information - Schedule of Information by Reportable Segment and a Reconciliation to Reported Amounts (Details) $ in Thousands	3 Months Ended			9 Months Ended
	Dec. 31, 2024 segment	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) segment	Sep. 30, 2023 USD ($)
Segment Reporting Information [Line Items]
Number of reportable segments | segment				4
Net sales		$ 620,501	$ 593,381	$ 2,011,922	$ 1,969,034
Segment operating income		82,067	78,605	309,471	309,999
Reconciling items:
Interest expense, net		(13,187)	(9,389)	(40,367)	(30,234)
Income before income taxes		68,473	68,298	267,815	277,755
Forecast
Segment Reporting Information [Line Items]
Number of reportable segments | segment	3
Operating Segments
Segment Reporting Information [Line Items]
Net sales		620,501	593,381	2,011,922	1,969,034
Segment operating income		86,632	81,291	329,436	322,236
Reconciling Items
Reconciling items:
Interest expense, net		(13,187)	(9,389)	(40,367)	(30,234)
Non-service cost component of net periodic benefit cost		(875)	(844)	(2,438)	(2,501)
Other		(4,097)	(2,760)	(18,816)	(11,746)
Titleist golf balls | Operating Segments
Segment Reporting Information [Line Items]
Net sales		190,560	192,557	646,017	622,125
Segment operating income		31,150	43,770	134,334	131,591
Titleist golf clubs | Operating Segments
Segment Reporting Information [Line Items]
Net sales		213,907	181,045	595,311	549,846
Segment operating income		49,930	36,509	124,670	118,455
Titleist golf gear | Operating Segments
Segment Reporting Information [Line Items]
Net sales		51,574	47,657	188,661	184,571
Segment operating income		4,246	788	28,270	26,657
FootJoy golf wear | Operating Segments
Segment Reporting Information [Line Items]
Net sales		133,137	136,669	482,753	500,174
Segment operating income		502	(1,469)	34,814	32,927
Other | Operating Segments
Segment Reporting Information [Line Items]
Net sales		31,323	35,453	99,180	112,318
Segment operating income		$ 804	$ 1,693	$ 7,348	$ 12,606

Segment Information - Schedul_2

Segment Information - Schedule of Net Sales By Geographical Area (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Total net sales	$ 620,501	$ 593,381	$ 2,011,922	$ 1,969,034
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Total net sales	374,219	352,463	1,200,989	1,123,766
EMEA
Revenues from External Customers and Long-Lived Assets [Line Items]
Total net sales	75,496	75,643	263,850	266,502
Japan
Revenues from External Customers and Long-Lived Assets [Line Items]
Total net sales	41,738	39,035	108,731	118,183
Korea
Revenues from External Customers and Long-Lived Assets [Line Items]
Total net sales	67,091	65,652	226,167	241,267
Rest of World
Revenues from External Customers and Long-Lived Assets [Line Items]
Total net sales	$ 61,957	$ 60,588	$ 212,185	$ 219,316

Commitments and Contingencies_2

Commitments and Contingencies (Details) $ in Thousands	Sep. 30, 2024 USD ($)
Payments Due by Period
Remainder of 2024	$ 237,533
2025	62,158
2026	5,392
2027	2,483
2028	2,417
Thereafter	$ 7,240

Restructuring Costs - Additiona

Restructuring Costs - Additional Information (Details) - VBR $ in Millions	Sep. 30, 2024 USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring costs incurred to date	$ 7
Expected remaining cost	$ 12

Restructuring Costs - Schedule

Restructuring Costs - Schedule of Company's Restructuring Program Rollforward (Details) - VBR - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2024
Restructuring Reserve [Roll Forward]
Balance at beginning of period	$ 2,013	$ 0
Provision	0	6,967
Payments	(386)	(5,340)
Balance at end of period	$ 1,627	$ 1,627

Other Business Developments (De

Other Business Developments (Details) - USD ($) $ in Thousands	1 Months Ended	9 Months Ended
	Jan. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Business Acquisition [Line Items]
Payments to acquire intangible assets		$ 0	$ 25,235
Trademarks, Domains and Products | Club Glove
Business Acquisition [Line Items]
Payments to acquire intangible assets	$ 25,200
Cash consideration	22,200
Asset acquisition, contingent consideration	$ 3,000
Weighted average useful life	10 years